Drug Development, Drugs and Pharmaceutical Companies

First spaceflight mission for drug development lab

Drug Discovery World

NOVEMBER 1, 2023

Redwire will launch its in-space pharmaceutical manufacturing platform, PIL-BOX, onboard SpaceX’s 29th cargo resupply services mission (SpaceX-29) for NASA to the International Space Station (ISS). The post First spaceflight mission for drug development lab appeared first on Drug Discovery World (DDW).

Drug Development

Drug Development Pharmaceuticals Drugs Pharmaceutical Companies

Key drug development trends and predictions for 2024

Drug Discovery World

FEBRUARY 19, 2024

Dr Julie Warner is Vice President of Regulatory Affairs at drug development consultancy, Boyds. In this article, she provides her expert insights into the key trends and developments expected to shape the global drug development industry this year. antibody-drug conjugate [ADC] pipelines in some oncology settings).

Drug Development

Drug Development Small Molecule Drugs Therapies

Mathematical model can speed up Alzheimer’s drug development

Drug Discovery World

NOVEMBER 29, 2023

The simulator could also be used by pharmaceutical companies to rapidly test multiple drug therapies and patient scenarios, increasing the speed and cost of drug development. The post Mathematical model can speed up Alzheimer’s drug development appeared first on Drug Discovery World (DDW).

Drug Development

Drug Development Pharmaceutical Companies Drugs FDA Approval

What recent paediatric guidelines mean for drug developers

Drug Discovery World

JULY 25, 2023

Justin Hay , Senior Director, Amy Cheung Senior Director of Integrated Drug Development, and Patrick Loebs Director, at Certara, examine recent changes in paediatric guidelines and how they affect drug development projects. In addition to describing the ethical framework (eg.

Drug Development

Drug Development Clinical Pharmacology Pharmacokinetics Drugs

How AI can be utilised to improve rare disease drug development

Drug Discovery World

MARCH 2, 2023

Rare disease drugs can be complicated and expensive to produce, with a limited patient pool their development is often slow and their cost price to the UK’s health service high. Investing into AI in healthcare is therefore crucial for those living with a rare disease in the UK and the development of life-changing drugs.

Drug Development

Drug Development Disease Clinical Trials Drugs

Late-stage drug failures drive toxicology testing market growth

Drug Discovery World

FEBRUARY 26, 2024

Factors such as an increased need to check late-stage drug failures with the adoption of more appropriate toxicity testing methods by pharmaceutical companies are expected to aid revenue generation for the market. Advancements in testing methods are likely to speed up the drug discovery process and boost the market growth.

Marketing

Marketing Drugs Pharmaceutical Companies Pharmaceuticals

Navigating the challenges and opportunities of AI in drug development and personalised medicine

Drug Target Review

JULY 18, 2023

Artificial Intelligence (AI) is poised to transform the field of target discovery in drug development, offering immense potential to enhance efficacy, personalised medicine, and accelerate the development of innovative compounds. This means that we are not doing something right.

Drug Development

Drug Development Drugs Pharmaceutical Companies Clinical Development

How Drug Development CMC Works

DS in Pharmatics

FEBRUARY 27, 2023

When pharmaceutical companies develop a new drug product for the market, there are many different steps a potential product must go through to determine and control its safety, manufacturability, effectiveness and reliability. CMC is done during […]

Drug Development

Drug Development Pharmaceutical Companies Drugs Pharmaceuticals

Unlocking neuroscience drug discovery

Drug Discovery World

OCTOBER 2, 2023

DDW has published the latest addition to its Guide Series, ‘Unlocking neuroscience drug discovery’. It covers the way the neuroscience sector is overcoming drug discovery challenges, advances in neuroscience and the era of precision neuroscience.

Pharmaceutical Companies

Pharmaceutical Companies Drugs Pharmaceuticals Drug Development

Europe: Where is the drug discovery innovation?

Drug Discovery World

MAY 6, 2024

In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. Europe is traditionally a life sciences powerhouse, with a strong tradition in pharmaceutical discovery. In 2022, the continent held a 22.4% billion ($7.9

Drugs

Drugs Molecular Biology Science Clinical Trials

Is AI the answer to the challenges facing drug discovery?

Drug Discovery World

FEBRUARY 13, 2024

Often this can be drug approvals, exciting research into hard-to-treat indications, or even regulatory updates that enable players within the sector to utilise the latest technologies and drive therapies to market faster, ultimately benefitting patients. But is AI the answer to the industry’s development challenges?

Small Molecule

Small Molecule Drugs Therapies Pharmaceutical Companies

Highs and lows of drug repurposing

Drug Discovery World

SEPTEMBER 26, 2022

DDW Editor Reece Armstrong explores the rise of drug repurposing and the benefits and disadvantages it brings to drug discovery and development. . Drug repurposing, the act of finding new clinical targets for both approved and unapproved drugs, has emerged as a viable alternative to traditional drug discovery approaches. .

Pharmaceutical Companies

Pharmaceutical Companies Drugs Pharmaceuticals Clinical Trials

Biotech funding recovery predicted for 2024

Drug Discovery World

JANUARY 10, 2024

As patent cliffs loom for large pharmaceutical companies, they may choose to do more partnerships, merger and acquisition (M&A) deals with biotechs to enhance their drug development and innovation. The post Biotech funding recovery predicted for 2024 appeared first on Drug Discovery World (DDW).

Pharmaceutical Companies

Pharmaceutical Companies Marketing International Pharmaceuticals

$11.4m raised to power a ‘precision medicine revolution’

Drug Discovery World

JANUARY 23, 2024

Solving bottlenecks in precision medicine R&D Medical trials underpin modern healthcare yet clinical research is an incredibly complex and time-consuming process for both patients and companies running trials, including pharmaceutical companies and emerging biotech startups.

Clinical Trials

Clinical Trials Pharmaceutical Companies Trials Drug Development

Pfizer and CytoReason collaborate to bolster AI in drug discovery

Drug Discovery World

SEPTEMBER 22, 2022

Pfizer has extended its multi-year partnership with CytoReason to use CytoReason’s artificial intelligence (AI) technology for Pfizer’s drug development programs. . CytoReason’s platform has reportedly provided Pfizer with insights in research and development programs across over 20 diseases. .

Pharmaceutical Companies

Pharmaceutical Companies Drugs Licensing Licensing

This week in drug discovery (29 May – 2 June)

Drug Discovery World

JUNE 2, 2023

With National Cancer Research Month coming to an end and the American Society of Clinical Oncology Annual Meeting currently taking place in Chicago (2-6 June), it’s been another busy week for cancer drug development news. The post This week in drug discovery (29 May – 2 June) appeared first on Drug Discovery World (DDW).

Pharmaceutical Companies

Pharmaceutical Companies Clinical Trials Drugs Pharmaceuticals

Synthetic biology: Innovating in drug discovery

Drug Discovery World

AUGUST 1, 2023

Synthetic biology is increasingly important to drug discovery and development. Partnerships Earlier this year cell-engineering company MaxCyte signed a strategic platform license (SPL) with biotechnology company Catamaran Bio. Human model systems such as organoids are the future of our industry.

Licensing

Licensing Licensing Engineering Drugs

This week in drug discovery (7-11 November)

Drug Discovery World

NOVEMBER 11, 2022

The drug discovery community also gained new insights into the inner workings of a new class of cancer drugs and how monkeypox adapts to evade treatments. . Scientists uncover secret to success in new class of cancer drugs . Researchers reveal how monkeypox evolves to evade drugs . The top stories: .

Pharma Companies

Pharma Companies Drugs Pharmaceutical Companies Disease

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

OCTOBER 16, 2023

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. There is a range of reasons why this area has become focal point for drug discovery, one of which is the fact that it encompasses the University of Oxford and the University of Cambridge, two of the oldest and most prestigious universities in the world.

Drugs

Drugs Science Therapies Targeted Protein Degradation

Scandinavia: insight into opportunities for drug discovery

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals.

Science

Science Drugs Pharmaceutical Companies Pharmaceuticals

Unleashing AI in Drug Discovery: Prospects and Challenges

DrugBank

APRIL 12, 2024

Over the past decade, the drug discovery landscape has been revolutionized by the adoption of artificial intelligence (AI) and machine learning (ML), witnessing early adopters leapfrog into pioneering technologies aimed at streamlining the drug development process and curtailing associated costs.

Drugs

Drugs Pharmaceutical Companies Clinical Trials Pharmaceuticals

FSP Engagements Continue to Gain Popularity, Drive Success

PPD

MARCH 26, 2024

The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.

Pharmaceutical Companies

Pharmaceutical Companies Clinical Research Clinical Development Drug Development

Cambridge Cognition set to become key player in virtual clinical trials

Drug Discovery World

OCTOBER 14, 2022

Cambridge Cognition has entered into an agreement to acquire eClinicalHealth Ltd (eCH), a full-service digital technology provider that is working on virtual clinical trials for three of the world’s top ten largest pharmaceutical companies. . billion with a projected growth of 14% per annum 1. GlobalData.

Clinical Trials

Clinical Trials Trials Pharmaceutical Companies Pharmaceuticals

Q&A with Mark Garner: The golden age of cancer research

Drug Discovery World

JULY 5, 2023

A big part of precision oncology is companion diagnostics, to determine if a patient will respond to a drug. Companion diagnostics are vital for the development of precision oncology treatments which are more targeted, more specific, and are less likely to have side effects. RA: How is Agilent supporting cancer research?

Research

Research Immune Response Pharmaceutical Companies Treatment

The three key stages to a successful specialty drug launch

Drug Discovery World

FEBRUARY 22, 2023

Craig Caceci, Managing Director at Terebellum, offers guidance to pharmaceutical companies that are in the position to take their drugs to market. The challenges are even greater in the case of orphan drugs where patients need to be identified; therefore, emphasis is on diagnosis. There are many questions to ask.

Specialty Pharmacies

Specialty Pharmacies Drugs Marketing Clinical Trials

Microscopic innovations in women’s health

Drug Discovery World

SEPTEMBER 28, 2023

Earlier this year, we explored the microbiome and its role in drug development across various therapeutic areas. Women’s health microbiome-based drug development landscape Despite their limited historical interest, pharma/biotech companies are now increasingly interested in the female microbiome and its role in drug development.

Clinical Trials

Clinical Trials Regulations Trials Drug Development

£30m initiative will support early-stage antimicrobial development

Drug Discovery World

OCTOBER 19, 2023

Until recently many large pharmaceutical companies had stopped antibiotic research as the returns on investment were too low and regulatory requirements too stringent. Bacteria and other microbes are evolving to become resistant to treatment, driven in large part by our overuse of antibiotics. million available per project.

Pharmaceutical Companies

Pharmaceutical Companies Science Treatment Pharmaceuticals

Drug discovery hotspots: Focus on Qatar

Drug Discovery World

MARCH 7, 2023

DDW Editor Reece Armstrong takes a look at Qatar’s drug discovery and life sciences market, exploring how the country is utilising innovative technologies in its approach to healthcare. The Middle East represents one of the world’s most lucrative markets for pharmaceuticals.

Drugs

Drugs Pharmaceuticals Marketing Disease

Norgine appoints new COO to drive European position

Drug Discovery World

SEPTEMBER 15, 2023

Specialist pharmaceutical company Norgine has appointed Saulo Martiniano as its new Chief Operating Officer (COO). ” The post Norgine appoints new COO to drive European position appeared first on Drug Discovery World (DDW).

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceuticals Production Marketing

The Race for Ozempic Alternatives: Unlocking the Future of Weight Loss Medication

DrugBank

MARCH 7, 2024

The landscape of weight loss drugs has been rapidly evolving, and 2024 is poised to be another transformative year in this market. Pharmaceutical researchers, in particular, have a keen interest in understanding the unfolding dynamics of this market.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceuticals Clinical Trials Pharmacokinetics

A review of Japan’s drug discovery and development landscape

Drug Discovery World

OCTOBER 20, 2022

DDW Multimedia Editor Megan Thomas takes a broad look at the drug discovery and development landscape in Japan and highlights how it is bolstered by government policies, investment, collaboration, start-up ecosystems and academic research. . Similarly, biosimilars are expected to grow. Government policies . Real-world evidence .

International

International Drugs Science Government

Pistoia Alliance announces Japanese R&D partnerships

Drug Discovery World

JUNE 15, 2023

Matador was founded to build a bridge between overseas technology firms and Japanese pharmaceutical companies, and collaboration is critical to this aim. The post Pistoia Alliance announces Japanese R&D partnerships appeared first on Drug Discovery World (DDW).

Pharmaceutical Companies

Pharmaceutical Companies Science Hospitals Pharmaceuticals

Advancing paediatric cancer research through partnerships

Drug Discovery World

DECEMBER 28, 2023

But over the course of my career, I have seen the tides begin to turn as practicing clinicians, researchers, advocacy groups and pharmaceutical companies advance conversations around the needs of our shared north star – the patient. In many ways, it is fortunate that paediatric cancer is considered a rarity by the medical community.

Research

Research Clinical Trials Hospitals Trials

MPAACT Consortium Unites Industry and Academia to Establish Measurable Residual Disease as a Surrogate Endpoint in Acute Myeloid Leukemia Drug Development

The Pharma Data

MAY 5, 2022

Validated Measurable Residual Disease Assays are Critical for the Rapid Development of Future Novel Therapeutics for Patients with Acute Myeloid Leukemia. Most often, AML develops from cells that would turn into white blood cells (other than lymphocytes), but sometimes AML develops in other types of blood-forming cells.

Disease

Disease Drug Development Clinical Trials Pharmaceutical Companies

Why Clinical Trial Success Criteria Matters: 5 Essential Questions

H1 Blog

DECEMBER 4, 2023

As the pharmaceutical and biotech industries continue to push for faster drug development, the importance of equity and diversity in clinical trial recruitment cannot be overlooked. Let’s dive in to uncover the role of digital health and data in driving faster drug development through improved diversity.

Clinical Trials

Clinical Trials Trials Pharmaceutical Companies Clinical Research

How to Fast-Track Clinical Research Timelines

PPD

JUNE 20, 2024

To accelerate clinical research timelines, pharmaceutical developers need to tap into solutions that demonstrably streamline drug development from start to finish. The finish line: Powering your success It’s time for pharmaceutical developers to make clinical research timelines work for them, not against them.

Clinical Research

Clinical Research Research Pharmaceuticals Clinical Trials

How Regulatory Affairs Consultants Could Help Your Company

DS in Pharmatics

FEBRUARY 24, 2023

Drug development is an immensely complex undertaking consisting of many different, interconnected processes. Specialist regulatory affairs consultants offer services to companies operating across this challenging industry.

Pharmaceutical Companies

Pharmaceutical Companies Regulations Pharmaceuticals Drug Development

ACI To Host Multiple Events Featuring HP&M Speakers – Discounts Available to FDA Law Blog Readers

FDA Law Blog: Drug Discovery

MARCH 6, 2024

Charles assists clients across a range of FDA-related regulatory matters by providing timely strategic advice on new drug and biologic development and helping them tackle complex regulatory issues.

FDA

FDA Compliance Pharmaceuticals Regulations

The Power of Personalization Amid the Changing CRO Landscape

Conversations in Drug Development Trends

DECEMBER 7, 2023

At Worldwide, we understand that every program is different, which means every drug development path forward will be unique. Rather than settling for an “off-the-shelf” approach, you deserve a team that actively seeks customized solutions tailored to your specific study.

Clinical Trials

Clinical Trials Clinical Development Trials Pharmaceutical Companies

Get Prepared for New Plastic Packaging and Manufacturing Materials Requirements

PPD

JULY 20, 2023

In clinical research, the role of drug packaging systems cannot be overlooked. Industry guidelines require biopharmaceutical and biotechnology companies to test their pharmaceutical packaging systems, as the systems often experience prolonged and intimate contact with drug products, drug substances and intermediates.

Packaging

Packaging Laboratories Compliance Pharmaceutical Companies

Best Practices for Veeva Vault Software Upgrades & Release Management

thought leadership

JUNE 19, 2023

Across biotech startups and global pharmaceutical companies alike, Veeva Vault continues to expand market share. With 1,300+ customers, Veeva Systems is one of the largest providers of cloud solutions for the life sciences industry.

Pharmaceutical Companies

Pharmaceutical Companies Science Pharmaceuticals Drug Development

Ageing and cancer-causing gene: researchers uncover a link

Drug Target Review

AUGUST 15, 2023

Prochownik, delved into the dual role of the Myc gene in both cancer development and ageing. The findings highlight the gene’s complex functions, opening up new avenues for cancer therapy and raising important considerations for future drug development.

Research

Research Pharmaceutical Companies Drug Development Therapies

Pfizer launches Phase III trial for Lyme disease vaccine

Drug Discovery World

AUGUST 12, 2022

Pfizer has launched a Phase III clinical trial of a vaccine to protect people against Lyme disease, in collaboration with pharmaceutical company Valneva. . The post Pfizer launches Phase III trial for Lyme disease vaccine appeared first on Drug Discovery World (DDW). Official comments . February 2022. Available at:?

Vaccine

Vaccine Disease Trials Pharmaceutical Companies

Four Ideas for Pharma to Maximize the Influence of Digital Opinion Leaders in Medicine

H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals

First spaceflight mission for drug development lab

Key drug development trends and predictions for 2024

Trending Sources

Mathematical model can speed up Alzheimer’s drug development

What recent paediatric guidelines mean for drug developers

How AI can be utilised to improve rare disease drug development

Late-stage drug failures drive toxicology testing market growth

Navigating the challenges and opportunities of AI in drug development and personalised medicine

How Drug Development CMC Works

Unlocking neuroscience drug discovery

Europe: Where is the drug discovery innovation?

Is AI the answer to the challenges facing drug discovery?

Highs and lows of drug repurposing

Biotech funding recovery predicted for 2024

$11.4m raised to power a ‘precision medicine revolution’

Pfizer and CytoReason collaborate to bolster AI in drug discovery

This week in drug discovery (29 May – 2 June)

Synthetic biology: Innovating in drug discovery

This week in drug discovery (7-11 November)

Where is the drug discovery expertise happening in the UK?

Scandinavia: insight into opportunities for drug discovery

Unleashing AI in Drug Discovery: Prospects and Challenges

FSP Engagements Continue to Gain Popularity, Drive Success

Cambridge Cognition set to become key player in virtual clinical trials

Q&A with Mark Garner: The golden age of cancer research

The three key stages to a successful specialty drug launch

Microscopic innovations in women’s health

£30m initiative will support early-stage antimicrobial development

Drug discovery hotspots: Focus on Qatar

Norgine appoints new COO to drive European position

The Race for Ozempic Alternatives: Unlocking the Future of Weight Loss Medication

A review of Japan’s drug discovery and development landscape

Pistoia Alliance announces Japanese R&D partnerships

Advancing paediatric cancer research through partnerships

MPAACT Consortium Unites Industry and Academia to Establish Measurable Residual Disease as a Surrogate Endpoint in Acute Myeloid Leukemia Drug Development

Why Clinical Trial Success Criteria Matters: 5 Essential Questions

How to Fast-Track Clinical Research Timelines

How Regulatory Affairs Consultants Could Help Your Company

ACI To Host Multiple Events Featuring HP&M Speakers – Discounts Available to FDA Law Blog Readers

The Power of Personalization Amid the Changing CRO Landscape

Get Prepared for New Plastic Packaging and Manufacturing Materials Requirements

Best Practices for Veeva Vault Software Upgrades & Release Management

Ageing and cancer-causing gene: researchers uncover a link

Pfizer launches Phase III trial for Lyme disease vaccine

Four Ideas for Pharma to Maximize the Influence of Digital Opinion Leaders in Medicine

Stay Connected